Related Experiment Video
Updated: May 29, 2025

Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry
Published on: April 21, 2022
METTL14-mediated m6A modification of DDIT4 promotes its mRNA stability in aging-related idiopathic pulmonary fibrosis
Dan Li1,2, Li Qian2, Yufeng Du2
1First Clinical Medical College, Shanxi Medical University, Taiyuan, China.
Abstract:
Although N6-methyladenosine (m6A) may be related to the pathogenesis of fibrotic process, the mechanism of m6A modification in aging-related idiopathic pulmonary fibrosis (IPF) remains unclear. Three-milliliter venous blood was collected from IPF patients and healthy controls. MeRIP-seq and RNA-seq were utilized to investigate differential m6A modification. The expressions of identified m6A regulator and target gene were validated using MeRIP-qPCR and real-time PCR. Moreover, we established an animal model and a senescent model of A549 cells to explore the associated molecular mechanism. Our study provided a panorama of m6A methylation in IPF. Increased peaks (3756) and decreased peaks (4712) were observed in the IPF group. The association analysis showed that 749 DEGs were affected by m6A methylation in IPF. Among the m6A regulators, the expression of METTL14 decreased in IPF. The m6A level of our interested gene DDIT4 decreased significantly, but the mRNA level of DDIT4 was higher in IPF. This was further verified in bleomycin-induced pulmonary fibrosis. At the cellular level, it was further confirmed that METTL14 and DDIT4 might participate in the senescence of alveolar epithelial cells. The downregulation of METTL14 might inhibit the decay of DDIT4 mRNA by reducing the m6A modification level of DDIT4 mRNA, leading to high expression of DDIT4 mRNA and protein. Our study provided a panorama of m6A alterations in IPF and discovered METTL14 as a potential intervention target for epigenetic modification in IPF. These results pave the way for future investigations regarding m6A modifications in aging-related IPF.
Insights
N6-methyladenosine (m6A) modification is altered in idiopathic pulmonary fibrosis (IPF). Downregulation of METTL14 impacts DDIT4 expression, suggesting a role in lung fibrosis pathogenesis.
Area of Science:
- Epigenetics
- Molecular Biology
- Pulmonary Medicine
Background:
- N6-methyladenosine (m6A) is implicated in fibrotic processes, but its role in aging-related idiopathic pulmonary fibrosis (IPF) is not well understood.
- Investigating m6A modification mechanisms in IPF is crucial for understanding disease pathogenesis.
Purpose of the Study:
- To elucidate the role and mechanism of m6A modification in aging-related IPF.
- To identify key m6A regulators and target genes involved in IPF.
Main Methods:
- MeRIP-seq and RNA-seq were used to analyze differential m6A modification and gene expression in IPF patients and controls.
- MeRIP-qPCR and real-time PCR validated key findings.
- Animal and cellular senescence models were employed to explore molecular mechanisms.
Main Results:
- IPF lungs showed significant alterations in m6A peaks, with more decreased than increased peaks.
- 749 differentially expressed genes (DEGs) were found to be affected by m6A methylation in IPF.
- The m6A regulator METTL14 was downregulated in IPF, correlating with decreased m6A modification and increased mRNA/protein levels of DDIT4, a gene implicated in alveolar epithelial cell senescence.
Conclusions:
- m6A alterations are prevalent in IPF, with METTL14 downregulation playing a potential role in disease progression.
- METTL14's effect on DDIT4 mRNA stability suggests a novel epigenetic mechanism in IPF pathogenesis.
- METTL14 represents a potential therapeutic target for epigenetic intervention in IPF.
More Related Videos
Related Concept Videos
RNA Stability
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
Nuclear Export of mRNA
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Abnormal Proliferation
RNA Editing

